2-Bromo-5-fluoro-4-trifluoromethylpyridine, 95.0%, 1g

(E)-3-(3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL)-2-METHYLACRYLIC ACID, 95.0%, 500mg

Columna HPLC NUCLEODUR® 100-3 C8 ec, 250 mm, 4,6 mm, 1 Pieza(s)

2-(3-Fluoro-4-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 10g

Dimethyl 2,2-dimethylpentanedioate, 97%, 1g

(R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 250mg

N-Hydroxyphthalimide>99.0%(T)100g

(4-(Methylamino)-3-nitrophenyl)methanol, 95%, 1g

3,3',5,5'-Tetrafluorobiphenyl-4,4'-dicarboxylic acid, 97%, 250mg

Chloromethyldimethylisopropoxysilane, 95%, 1g

CINACIGUAT, 95%, 25mg

TERT-BUTYL 4-FLUORO-3-OXOAZEPANE-1-CARBOXYLATE, 95.0%, 500mg

4-(4-Amino-3-fluorophenoxy)-N-methyl-2-pyridinecarboxamide>98.0%(HPLC)1g